New South Wales Consolidated Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Next] [Download] [Help]

WORKERS COMPENSATION REGULATION 2016 - SCHEDULE 2

SCHEDULE 2 – Medical tests and results--brucellosis, Q fever, leptospirosis and COVID-19

(Clauses 5 and 5B)

Part 1 - Medical tests and results--brucellosis, Q fever and leptospirosis

Column 1 Column 2 Column 3
Brucellosis Brucella agglutination titres or complement fixation titres between acute and convalescent phase serum samples (taken at least 2 weeks apart and, where possible, conducted at the same laboratory) IgG seroconversion or a four-fold or greater increase in antibody titre
A single high Brucella agglutination titre or complement fixation test An antibody titre of 640 or greater
A laboratory culture of any specimen The isolation of Brucella
Q fever Nucleic acid testing of a specimen Detection of Coxiella burnetii
Phase II antigen in sera taken at least 2 weeks apart and tested, in parallel, in the absence of recent Q fever vaccination Seroconversion or a four-fold or greater increase in antibody titre
A laboratory culture of any specimen The isolation of Coxiella burnetii
Q fever IgM in the absence of recent Q fever vaccination in a person with a clinically compatible illness: fever, sweating and chills, severe headache, myalgia and arthralgia, extreme fatigue, weakness and malaise Detection
Leptospirosis Leptospira agglutination titres between acute and convalescent phase sera (taken at least 2 weeks apart and, preferably, conducted at the same laboratory) A four-fold or greater increase in antibody titre
A single Leptospira micro agglutination titre supported by a positive EIA IgM result Greater than or equal to 400
A laboratory culture of any specimen The isolation of pathogenic leptospira species

Part 2 - Medical tests and results--COVID-19

Column 1 Column 2 Column 3
COVID-19 Nucleic acid testing of any specimen using a specific SARS-CoV-2 nucleic acid test that is listed in the Australian Register of Therapeutic Goods Detection of SARS-CoV-2
A laboratory culture of any specimen, with confirmatory testing using a PCR test that is listed n the Australian Register of Therapeutic Goods The isolation of SARS-CoV-2, confirmed with PCR


AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback